Helen I. Torley

Helen I. Torley

President and Chief Executive OfficeratHalozyme Therapeutics· In proxies 2021–2025

Pay in FY2025+82% from the year before · Halozyme Therapeutics stock +40.8% the same year

Helen I. Torley was paid $23.2M in FY2025 (Dec), up 82%. Halozyme Therapeutics stock rose 40.8% that year.

Pay$100 in the stock at the end of FY20 → $158
Pay is from the Summary Compensation Table of each Halozyme Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Halozyme TherapeuticsPublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role +203%
  2. Company’s Board of DirectorsPublic company
    • Director? – PresentNo stock prices for these years
  3. Directors:Public company
    • Director? – PresentNo stock prices for these years
  4. Quest Diagnostics IncorporatedPublic company
    • Director? – PresentNo stock prices for these years
  5. Recent Past Public Company Board ExperiencePublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?